Interleukin-36α as a potential biomarker for renal tubular damage induced by dietary phosphate load.


Journal

FEBS open bio
ISSN: 2211-5463
Titre abrégé: FEBS Open Bio
Pays: England
ID NLM: 101580716

Informations de publication

Date de publication:
05 2020
Historique:
received: 23 01 2020
revised: 05 03 2020
accepted: 17 03 2020
pubmed: 20 3 2020
medline: 10 7 2021
entrez: 20 3 2020
Statut: ppublish

Résumé

Excessive intake of phosphate has been known to induce renal tubular damage and interstitial inflammation, leading to acute kidney injury or chronic kidney disease in rodents and humans. However, sensitive and early biomarkers for phosphate-induced kidney damage remain to be identified. Our previous RNA sequencing analysis of renal gene expression identified interleukin-36α (IL-36α) as a gene significantly upregulated by dietary phosphate load in mice. To determine the time course and dose dependency of renal IL-36α expression induced by dietary phosphate load, we placed mice with or without uninephrectomy on a diet containing either 0.35%, 1.0%, 1.5%, or 2.0% inorganic phosphate for 10 days, 4 weeks, or 8 weeks and evaluated renal expression of IL-36α and other markers of tubular damage and inflammation by quantitative RT-PCR, immunoblot analysis, and immunohistochemistry. We found that IL-36α expression was induced in distal convoluted tubules and correlated with phosphate excretion per nephron. The increase in IL-36α expression was simultaneous with but more robust in amplitude than the increase in tubular damage markers such as Osteopontin and neutrophil gelatinase-associated lipocalin, preceding the increase in expression of other inflammatory cytokines, including transforming growth factor-α, interleukin-1β, and transforming growth factor-β1. We conclude that IL-36α serves as a marker that reflects the degree of phosphate load excreted per nephron and of associated kidney damage.

Identifiants

pubmed: 32191399
doi: 10.1002/2211-5463.12845
pmc: PMC7193159
doi:

Substances chimiques

Biomarkers 0
Cytokines 0
Interleukin-1alpha 0
Interleukins 0
Phosphates 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

894-903

Informations de copyright

© 2020 The Authors. Published by FEBS Press and John Wiley & Sons Ltd.

Références

J Clin Invest. 2005 Mar;115(3):610-21
pubmed: 15711640
Nephrol Dial Transplant. 2002 Jun;17(6):985-91
pubmed: 12032186
Nat Clin Pract Nephrol. 2008 Nov;4(11):606-14
pubmed: 18797448
Am J Physiol Renal Physiol. 2007 Dec;293(6):F1935-43
pubmed: 17898038
Nat Rev Nephrol. 2019 Jan;15(1):27-44
pubmed: 30455427
Nat Immunol. 2019 Sep;20(9):1138-1149
pubmed: 31427775
Nat Rev Nephrol. 2014 Nov;10(11):625-43
pubmed: 25266210
Lab Invest. 2010 Mar;90(3):459-75
pubmed: 20101239
Kidney Int. 2018 Mar;93(3):599-614
pubmed: 29241623
J Am Soc Nephrol. 2017 Jul;28(7):2022-2037
pubmed: 28179433
Lancet. 2005 Apr 2-8;365(9466):1231-8
pubmed: 15811456
Nat Commun. 2019 Sep 5;10(1):4003
pubmed: 31488830
J Immunol. 2009 Jul 15;183(2):787-91
pubmed: 19570822
J Am Soc Nephrol. 2011 Jan;22(1):124-36
pubmed: 21115613
Front Immunol. 2017 Oct 23;8:1346
pubmed: 29109726
iScience. 2018 Apr 27;2:238-268
pubmed: 30428375
Nat Rev Rheumatol. 2014 Nov;10(11):639-40
pubmed: 25201385
Nature. 1997 Nov 6;390(6655):45-51
pubmed: 9363890
Kidney Int. 1980 Jun;17(6):722-31
pubmed: 7412107

Auteurs

Yoshitaka Hirano (Y)

Division of Anti-aging Medicine, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Japan.
Department of Nephrology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.

Hiroshi Kurosu (H)

Division of Anti-aging Medicine, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Japan.

Kazuhiro Shiizaki (K)

Division of Anti-aging Medicine, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Japan.

Yoshitaka Iwazu (Y)

Division of Anti-aging Medicine, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Japan.
Department of Clinical Laboratory Medicine, Jichi Medical University, Shimotsuke, Japan.

Shuichi Tsuruoka (S)

Department of Nephrology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.

Makoto Kuro-O (M)

Division of Anti-aging Medicine, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Japan.
AMED-CREST, Japan Agency for Medical Research and Development, Tokyo, Japan.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH